Filing Details
- Accession Number:
- 0001127602-20-017883
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-05-26 14:37:19
- Reporting Period:
- 2020-05-22
- Accepted Time:
- 2020-05-26 14:37:19
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1100682 | Charles River Laboratories International Inc. | CRL | Services-Commercial Physical & Biological Research (8731) | 061397316 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1221496 | George Massaro | 251 Ballardvale Street Wilmington MA 01887 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2020-05-22 | 603 | $173.01 | 12,222 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-05-22 | 255 | $173.87 | 11,967 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-05-22 | 83 | $174.75 | 11,884 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- This sale occurred pursuant to a 10b5-1 Trading Plan.
- This transaction was executed in multiple trades at prices ranging from $172.46 to $173.40. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $173.575 to $174.43. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Billionaire Hedge Funds
